Featured ArticlesThe Latest

Clinical Benefits of Circadian-based Antioxidant Protection and Repair

By December 3, 2020No Comments

Featured Article

Featured Article

Skin activities follow endogenous circadian rhythms resulting in differences between daytime and nighttime properties. To address the variations in skin needs, a novel circadian-based dual serum system (LVS) was developed.

Read more

Skin activities follow endogenous circadian rhythms resulting in differences between daytime and nighttime properties. To address the variations in skin needs, a novel circadian-based dual serum system (LVS) was developed.

Zoe Diana Draelos, Elizabeth T Makino, Kuniko Kadoya, Audrey Nguyen, Lily I Jiang, Rahul C Mehta 

 

The concept of human body rhythms has been popularized as important in overall body health. These rhythms are characterized as fluctuations in mental, physical, and emotional well-being based on the clock. These fluctuations are related to the day/night cycle, hormones, meals, sleep/wake cycle, adrenal gland production, thyroid gland, and clock genes.

The study of the body circadian rhythm is known as chronobiology with studies of the body’s inner clock dating back to the 18th century. There are three types of chronobiology rhythms: infradian rhythms, ultraradian rhythms, and circadian rhythms. Infradian rhythms last more than 24 hours and are repeated only every few days, weeks, or months representing such activities as female menses. Ultradian rhythms are shorter than 24 hours and often last several hours, such as ingestion of food. Finally, circadian rhythms last 24 hours with distinctive day/night cycles.

Circadian rhythms are endogenous and adjusted to the local environment by cues call zeitgebers, meaning “time giver” in German. The 2017 Nobel prize in physiology or medicine was awarded for research in molecular mechanisms controlling circadian rhythms in fruit flies. In humans, the circadian clock is in the suprachiasmatic nucleus, located in the hypothalamus. Information is transmitted to the suprachiasmatic nucleus via the retina that contains specialized photosensitive ganglion cells. PER1 and PER2 genes are expressed in the suprachiasmatic nucleus representing the primary circadian pacemaker in the human brain. These circadian rhythms are also important in the skin with robust autonomic clocks in keratinocytes, fibroblasts, melanocytes, mast cells, and hair follicles.

Important skin functions affected by circadian rhythms include free radical production and neutralization, DNA damage and repair, keratinocyte/fibroblast differentiation and proliferation, and barrier and immune functioning. Direct and indirect antioxidant protection play an important role in supporting these circadian rhythm skin functions.

Read Full Article Now
Article Cited in this Post

You May Also Like

Journal of Drugs in Dermatology JDD Article About Antioxidant, Keratolytic, and Hydrating Treatment for Seborrheic Keratoses. Image from the Full Spectrum of Dermatology: A Diverse and Inclusive Atlas of a darker skin tone back or torso with a seborrheic keratoses.

Antioxidant, Keratolytic, and Hydrating Treatment for Seborrheic Keratoses

| Featured Articles, JDD Highlights, Latest News, The Latest | No Comments
JDD Spotlight: A Novel Topical Approach for Seborrheic Keratoses? Could a new topical formula change the way we manage seborrheic keratoses? In a pilot study, a unique blend of antioxidants,…

JDD in the News: Micropeptide Addresses Aging, Inflammation

| Acne, Derm Community, Featured Articles, JDD Highlights, JDD in the Media, The Latest | No Comments
A recent Journal of Drugs in Dermatology study about a micropeptide with anti-aging and anti-inflammatory effects made news in Dermatology Times. The study, “Acetyl Dipeptide-31 Amide: A Novel Cosmetic Anti-Inflammatory…
Journal of Drugs in Dermatology JDD Article About Guselkumab Efficacy by Psoriasis Disease Severity and Treatment History: VOYAGE 1 and 2 Post Hoc Analyses. Image from the Full Spectrum of Dermatology: A Diverse and Inclusive Atlas of a darker skin tone elbow with psoriasis.

Guselkumab Efficacy by Psoriasis Disease Severity and Treatment History: VOYAGE 1 and 2 Post Hoc Analyses

| Featured Articles, JDD Highlights, Latest News, Psoriasis, The Latest | No Comments
JDD Spotlight: Guselkumab’s 5-Year Promise in Psoriasis Curious about long-term breakthroughs in psoriasis care? A recent pooled analysis from the Phase 3 VOYAGE studies hints that guselkumab might be a…

Leave a Reply